The trademark application NOEBTRI was filed by Regeneron Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on July 28, 2022, and it was registered by office on November 4, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).